1 week Ago By ABMN Staff
Prudential Financial Inc. cut its position in SPDR S&P Biotech ETF ( NYSEARCA:XBI – Free Report ) by 89.9% in the fourth quarter, Holdings Channel reports.
The firm owned 2,495 shares of the exchange traded fund’s stock after selling 22,153 shares during the period. Prudential Financial Inc.’s holdings in SPDR S&P Biotech ETF were worth $225,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also recently added to or reduced their stakes in the company. Mirae Asset Securities USA Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 66.
7% in the fourth quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock valued at $135,090,000 after buying an additional 600,000 shares during the last quarter.
Proficio Capital Partners LLC increased its position in SPDR S&P Biotech ETF by 16,156.1% in the 4th quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock valued at $82,615,000 after acquiring an additional 911,686 shares during the period.
Raymond James Financial Inc. acquired a new position in SPDR S&P Biotech ETF in the 4th quarter valued at about $55,529,000. Whittier Trust Co.
raised its stake in SPDR S&P Biotech ETF by 3.1% during the 4th quarter. Whittier Trust Co.
now owns 320,740 shares of the exchange traded fund’s stock valued at $28,885,000 after acquiring an additional 9,713 shares during the last quarter. Finally, J.Safra Asset Management Corp lifted its position in SPDR S&P Biotech ETF by 461.
6% during the 4th quarter. J.Safra Asset Management Corp now owns 292,502 shares of the exchange traded fund’s stock worth $26,293,000 after acquiring an additional 240,415 shares during the period.
SPDR S&P Biotech ETF Trading Down 4.4 % Shares of XBI stock opened at $71.61 on Friday.
SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $105.47.
The business’s 50 day moving average is $85.69 and its two-hundred day moving average is $92.05.
The company has a market capitalization of $4.52 billion, a P/E ratio of 11.47 and a beta of 1.
00. SPDR S&P Biotech ETF Company Profile SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index.
The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. Featured Stories Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF ( NYSEARCA:XBI – Free Report ).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter ..
